Related Experiment Video
Updated: May 12, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Incentive to study drugs in children and other governmental initiatives: will patients with asthma benefit?
1Pediatric Pharmacology Research Unit Network, National Institute of Child Health and Human Development, Rockville, MD 20892, USA.
Insights
This article reviews regulations for pediatric drug trials and their impact on children with asthma. It also examines federal initiatives addressing the rise in childhood asthma, emphasizing the need for research into causes and prevention.
Area of Science:
- Pediatric pharmacology
- Environmental health
- Epidemiology
Background:
- Increasing prevalence of childhood asthma over the last 15 years.
- Unexplained rise in asthma occurrence necessitates comprehensive investigation.
- Need to identify causes, including aeroallergens, environmental, and genetic factors.
Purpose of the Study:
- Summarize regulations for pediatric drug trials.
- Analyze the impact of these regulations on children, especially those with asthma.
- Review federal initiatives addressing the asthma epidemic.
Main Methods:
- Review of current pediatric drug trial regulations.
- Analysis of government initiatives and their response to asthma trends.
- Literature review on factors contributing to asthma prevalence.
Main Results:
- Regulations aim to facilitate pediatric drug trials for safety and efficacy.
- Federal initiatives are in place to address the rise in childhood asthma.
- A multi-faceted approach is required to understand and prevent asthma.
Conclusions:
- Facilitating pediatric drug trials is crucial for ensuring safe and effective treatments.
- Understanding the causes of increased asthma prevalence is essential for developing preventive strategies.
- Coordinated efforts are needed to combat the childhood asthma epidemic.
Abstract:
This article summarizes current regulations that have been developed to facilitate the performance of pediatric drug trials and their impact on children, particularly those children affected with asthma. In addition, other initiatives that have been developed by the federal government in response to the unexplained increase of asthma occurrence during the last 15 years will be reviewed. In the face of an asthma epidemic, a comprehensive approach is needed to determine the causes for the increase in the prevalence rate and the role of aeroallergens and other environmental and genetic factors and to identify effective preventive measures. Clearly, facilitating drug trials to prove the safety and effectiveness of drugs is of paramount importance.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: